video-assisted thoracoscopic surgery
Conditions
Interventions
Group A:preoperative intercostal block with 2ml 1.19% ropivacaine + postoperative intercostal block with 2ml saline solution + patient-controlled ananlgesia
Group B:preoperative intercostal block with 2ml saline solution + postoperative intercostal block with 2ml 1.19% ropivacaine + patient-controlled ananlgesia
Group C:preoperative intercostal block with 2ml 1.19% ropivacaine + postoperative intercostal block with 2ml 1.19% ropivacaine + patient-controlled ananlgesia
Group D:preoperative intercostal block with 2ml saline solution + postoperative intercostal block with 2ml saline solution + patient-controlled ananlgesia
Sponsors
Department of Anesthesiology, the First Affiliated Hospital, College of Medicine, Zhejiang University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. patients with video-assisted thoracoscopic surgery; 2. ASA 1-3.
Exclusion criteria
Exclusion criteria: 1. preoperative thoracic pain; 2. continuous use of analgesics before surgery; 3. radiotherapy on the chest berore surgery; 4. the inability to express pain scores because of comorbidities such as mental retardation; 5. allergy to ropivacaine; 6. history of thoracic surgery; 7. surgical procedure including parietal pleura resection or chest wall resection.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| rescue analgesia;postoperative complications; | — |
Primary
| Measure | Time frame |
|---|---|
| The postoperative turn-on time of patient-controlled analgesia pump;The cumulative sufentanil consumption by patient-controlled analgesia pump within 24 hours after surgery;The cumulative press times of patient-controlled analgesia pump within 24 hours after surgery;VAS; | — |
Countries
China
Contacts
Public ContactXiangming Fang
Department of Anesthesiology, the First Affiliated Hospital, College of Medicine, Zhejiang University
Outcome results
None listed